The rising global incidence of chronic kidney disease (CKD) is anticipated to fuel the hemodialysis and peritoneal dialysis market forecast. More than 10% of the global population is expected to be affected by CKD due to factors such as an aging population, increasing diabetes and hypertension rates, which accelerate CKD progression to end-stage renal disease, requiring dialysis. CKD is most common among individuals aged 65 and older. In 2023, the CDC estimated that 35.5 million people in the U.S. were diagnosed with CKD.
The
report Hemodialysis and
Peritoneal Dialysis Market is projected to reach USD 126.2 billion by 2029 from USD 92.0
billion in 2024 at a CAGR of 6.5% during the forecast period.
Download
PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279
Browse
- 150 Market Data Tables
- 65 Figures
- 350 Pages and in-depth TOC on " Hemodialysis
and Peritoneal Dialysis Market - Global Forecast to 2029”
Some of the prominent key players are:
- Fresenius Medical Care AG & Co. KGaA
(Germany),
- Baxter International Inc. (US),
- Nipro Corporation (Japan),
- NIKKISO CO., LTD. (Japan), and many
more......
Mergers & acquisitions, investments & expansions,
partnerships & collaborations, and new product developments are some of the
major strategies adopted by these key players to enhance their positions in the
Hemodialysis and Peritoneal Dialysis Market.
Opportunity:
High growth potential of emerging markets
Emerging markets such as China, India, Brazil, are
expected to offer significant growth opportunities for players operating in the
POC diagnostics market. This is primarily due to the high and growing
prevalence of diabetes, chronic kidney diseases, in these countries. As
economic growth in China and India continues to expand, there is rise in
healthcare spending across these countries, which leads to improved
affordability of hemodialysis and peritoneal dialysis treatment. According to
the article published by BMC Nephrology in 2023, in China, the prevalence of
ESRD is projected to reach 1,505 patients per million population by 2025. To
meet the increasing demand for dialysis in the emerging markets, players focus
on acquiring or entering into agreements and partnerships with healthcare
providers.
Market Segmentation: -
- The hemodialysis market is segmented
based on product and service. Hemodialysis products include hemodialysis
machines and hemodialysis consumables & supplies, whereas hemodialysis
services include in-center services and home services. The hemodialysis
services segment is anticipated to grow at significant rate during the
forecast period.
- Based on end users, home care setting is
expected to grow at a significant rate owing to growing preference of
patients for home hemodialysis modality, technological advancements, and
the cost-effectiveness of home dialysis treatment over incentre dialysis
procedures.
- On the basis of region, the hemodialysis
and peritoneal dialysis market is segmented into North America, Europe,
Asia Pacific, and the Latin America, Middle East & Africa. The
Asia-Pacific market is likely to witness significant market growth. This is
attributed to the rise in geriatric patient population, increasing cases
of chronic kidney diseases, moreover improving healthcare infrastructure
and the implementation of supportive government initiatives to increase
the accessibility of dialysis services in many APAC countries such as
India and China.
Recent Developments of
Hemodialysis and Peritoneal Dialysis Industry:
- In July 2023, Rockwell Medical
acquired the hemodialysis concentrates business from Evoqua Water
Technologies, strengthening its presence in the hemodialysis market
- In January 2022, Nextkidney BV
acquired Dialyss Pte Ltd, enhancing its technology capabilities in home
hemodialysis
- In March 2021, DaVita Inc. signed an agreement with Fresenius Medical Care AG & Co. KGaA for the expansion of the usage of NxStage Home Hemodialysis Machines
The escalating global prevalence of chronic kidney disease, spurred by growing aging population coupled with the increasing cases of diabetes and hypertension are fuelling the demand for renal replacement therapy including hemodialysis and peritoneal dialysis products and services. Ongoing technological advancements in dialysis technology, growing patient preference of home dialysis, supporting reimbursement policies and government initiatives and funding for healthcare infrastructure, enabling expansion of hospitals and dialysis centers further enhancing the accessibility of hemodialysis and peritoneal dialysis services among patients with end-stage renal disease (ESRD) are likely to drive the market growth during the forecast period.
Content Source: -
Hemodialysis and Peritoneal Dialysis Market Report
Hemodialysis and Peritoneal Dialysis Market Press
Release
No comments:
Post a Comment